Global Infectious Disease Drugs Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Infectious Disease Drugs Market Size 2017-2028

2.1.2 Infectious Disease Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Infectious Disease Drugs Segment by Type

2.2.1 Antibacterials

2.2.2 Antiviral drugs

2.2.3 Antiparasitic drugs

2.2.4 Antifungal

2.2.5 Others

2.3 Infectious Disease Drugs Market Size by Type

2.3.1 Infectious Disease Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Infectious Disease Drugs Market Size Market Share by Type (2017-2022)

2.4 Infectious Disease Drugs Segment by Application

2.4.1 HIV

2.4.2 Malaria

2.4.3 Hepatitis

2.4.4 Influenza

2.4.5 HPV

2.4.6 Tuberculosis

2.4.7 Others

2.5 Infectious Disease Drugs Market Size by Application

2.5.1 Infectious Disease Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Infectious Disease Drugs Market Size Market Share by Application (2017-2022)

3 Infectious Disease Drugs Market Size by Player

3.1 Infectious Disease Drugs Market Size Market Share by Players

3.1.1 Global Infectious Disease Drugs Revenue by Players (2020-2022)

3.1.2 Global Infectious Disease Drugs Revenue Market Share by Players (2020-2022)

3.2 Global Infectious Disease Drugs Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Infectious Disease Drugs by Regions

4.1 Infectious Disease Drugs Market Size by Regions (2017-2022)

4.2 Americas Infectious Disease Drugs Market Size Growth (2017-2022)

4.3 APAC Infectious Disease Drugs Market Size Growth (2017-2022)

4.4 Europe Infectious Disease Drugs Market Size Growth (2017-2022)

4.5 Middle East & Africa Infectious Disease Drugs Market Size Growth (2017-2022)

5 Americas

5.1 Americas Infectious Disease Drugs Market Size by Country (2017-2022)

5.2 Americas Infectious Disease Drugs Market Size by Type (2017-2022)

5.3 Americas Infectious Disease Drugs Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Infectious Disease Drugs Market Size by Region (2017-2022)

6.2 APAC Infectious Disease Drugs Market Size by Type (2017-2022)

6.3 APAC Infectious Disease Drugs Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Infectious Disease Drugs by Country (2017-2022)

7.2 Europe Infectious Disease Drugs Market Size by Type (2017-2022)

7.3 Europe Infectious Disease Drugs Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Infectious Disease Drugs by Region (2017-2022)

8.2 Middle East & Africa Infectious Disease Drugs Market Size by Type (2017-2022)

8.3 Middle East & Africa Infectious Disease Drugs Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Infectious Disease Drugs Market Forecast

10.1 Global Infectious Disease Drugs Forecast by Regions (2023-2028)

10.1.1 Global Infectious Disease Drugs Forecast by Regions (2023-2028)

10.1.2 Americas Infectious Disease Drugs Forecast

10.1.3 APAC Infectious Disease Drugs Forecast

10.1.4 Europe Infectious Disease Drugs Forecast

10.1.5 Middle East & Africa Infectious Disease Drugs Forecast

10.2 Americas Infectious Disease Drugs Forecast by Country (2023-2028)

10.2.1 United States Infectious Disease Drugs Market Forecast

10.2.2 Canada Infectious Disease Drugs Market Forecast

10.2.3 Mexico Infectious Disease Drugs Market Forecast

10.2.4 Brazil Infectious Disease Drugs Market Forecast

10.3 APAC Infectious Disease Drugs Forecast by Region (2023-2028)

10.3.1 China Infectious Disease Drugs Market Forecast

10.3.2 Japan Infectious Disease Drugs Market Forecast

10.3.3 Korea Infectious Disease Drugs Market Forecast

10.3.4 Southeast Asia Infectious Disease Drugs Market Forecast

10.3.5 India Infectious Disease Drugs Market Forecast

10.3.6 Australia Infectious Disease Drugs Market Forecast

10.4 Europe Infectious Disease Drugs Forecast by Country (2023-2028)

10.4.1 Germany Infectious Disease Drugs Market Forecast

10.4.2 France Infectious Disease Drugs Market Forecast

10.4.3 UK Infectious Disease Drugs Market Forecast

10.4.4 Italy Infectious Disease Drugs Market Forecast

10.4.5 Russia Infectious Disease Drugs Market Forecast

10.5 Middle East & Africa Infectious Disease Drugs Forecast by Region (2023-2028)

10.5.1 Egypt Infectious Disease Drugs Market Forecast

10.5.2 South Africa Infectious Disease Drugs Market Forecast

10.5.3 Israel Infectious Disease Drugs Market Forecast

10.5.4 Turkey Infectious Disease Drugs Market Forecast

10.5.5 GCC Countries Infectious Disease Drugs Market Forecast

10.6 Global Infectious Disease Drugs Forecast by Type (2023-2028)

10.7 Global Infectious Disease Drugs Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Information

11.1.2 GlaxoSmithKline Infectious Disease Drugs Product Offered

11.1.3 GlaxoSmithKline Infectious Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 GlaxoSmithKline Main Business Overview

11.1.5 GlaxoSmithKline Latest Developments

11.2 Gilead Sciences

11.2.1 Gilead Sciences Company Information

11.2.2 Gilead Sciences Infectious Disease Drugs Product Offered

11.2.3 Gilead Sciences Infectious Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Gilead Sciences Main Business Overview

11.2.5 Gilead Sciences Latest Developments

11.3 Merck & Co.

11.3.1 Merck & Co. Company Information

11.3.2 Merck & Co. Infectious Disease Drugs Product Offered

11.3.3 Merck & Co. Infectious Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Merck & Co. Main Business Overview

11.3.5 Merck & Co. Latest Developments

11.4 Pfizer

11.4.1 Pfizer Company Information

11.4.2 Pfizer Infectious Disease Drugs Product Offered

11.4.3 Pfizer Infectious Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Pfizer Main Business Overview

11.4.5 Pfizer Latest Developments

11.5 Sanofi

11.5.1 Sanofi Company Information

11.5.2 Sanofi Infectious Disease Drugs Product Offered

11.5.3 Sanofi Infectious Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Sanofi Main Business Overview

11.5.5 Sanofi Latest Developments

11.6 AbbVie

11.6.1 AbbVie Company Information

11.6.2 AbbVie Infectious Disease Drugs Product Offered

11.6.3 AbbVie Infectious Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 AbbVie Main Business Overview

11.6.5 AbbVie Latest Developments

11.7 Shire

11.7.1 Shire Company Information

11.7.2 Shire Infectious Disease Drugs Product Offered

11.7.3 Shire Infectious Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Shire Main Business Overview

11.7.5 Shire Latest Developments

11.8 Grifols

11.8.1 Grifols Company Information

11.8.2 Grifols Infectious Disease Drugs Product Offered

11.8.3 Grifols Infectious Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Grifols Main Business Overview

11.8.5 Grifols Latest Developments

11.9 Johnson & Johnson

11.9.1 Johnson & Johnson Company Information

11.9.2 Johnson & Johnson Infectious Disease Drugs Product Offered

11.9.3 Johnson & Johnson Infectious Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Johnson & Johnson Main Business Overview

11.9.5 Johnson & Johnson Latest Developments

11.10 Protein Sciences

11.10.1 Protein Sciences Company Information

11.10.2 Protein Sciences Infectious Disease Drugs Product Offered

11.10.3 Protein Sciences Infectious Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Protein Sciences Main Business Overview

11.10.5 Protein Sciences Latest Developments

11.11 AstraZeneca

11.11.1 AstraZeneca Company Information

11.11.2 AstraZeneca Infectious Disease Drugs Product Offered

11.11.3 AstraZeneca Infectious Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 AstraZeneca Main Business Overview

11.11.5 AstraZeneca Latest Developments

12 Research Findings and Conclusion

Table 1. Infectious Disease Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Antibacterials

Table 3. Major Players of Antiviral drugs

Table 4. Major Players of Antiparasitic drugs

Table 5. Major Players of Antifungal

Table 6. Major Players of Others

Table 7. Infectious Disease Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Infectious Disease Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Infectious Disease Drugs Market Size Market Share by Type (2017-2022)

Table 10. Infectious Disease Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Infectious Disease Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Infectious Disease Drugs Market Size Market Share by Application (2017-2022)

Table 13. Global Infectious Disease Drugs Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Infectious Disease Drugs Revenue Market Share by Player (2020-2022)

Table 15. Infectious Disease Drugs Key Players Head office and Products Offered

Table 16. Infectious Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Infectious Disease Drugs Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Infectious Disease Drugs Market Size Market Share by Regions (2017-2022)

Table 21. Americas Infectious Disease Drugs Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Infectious Disease Drugs Market Size Market Share by Country (2017-2022)

Table 23. Americas Infectious Disease Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Infectious Disease Drugs Market Size Market Share by Type (2017-2022)

Table 25. Americas Infectious Disease Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Infectious Disease Drugs Market Size Market Share by Application (2017-2022)

Table 27. APAC Infectious Disease Drugs Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Infectious Disease Drugs Market Size Market Share by Region (2017-2022)

Table 29. APAC Infectious Disease Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Infectious Disease Drugs Market Size Market Share by Type (2017-2022)

Table 31. APAC Infectious Disease Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Infectious Disease Drugs Market Size Market Share by Application (2017-2022)

Table 33. Europe Infectious Disease Drugs Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Infectious Disease Drugs Market Size Market Share by Country (2017-2022)

Table 35. Europe Infectious Disease Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Infectious Disease Drugs Market Size Market Share by Type (2017-2022)

Table 37. Europe Infectious Disease Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Infectious Disease Drugs Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Infectious Disease Drugs Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Infectious Disease Drugs Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Infectious Disease Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Infectious Disease Drugs Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Infectious Disease Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Infectious Disease Drugs Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Infectious Disease Drugs

Table 46. Key Market Challenges & Risks of Infectious Disease Drugs

Table 47. Key Industry Trends of Infectious Disease Drugs

Table 48. Global Infectious Disease Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Infectious Disease Drugs Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Infectious Disease Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Infectious Disease Drugs Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Infectious Disease Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Infectious Disease Drugs Market Size Market Share Forecast by Application (2023-2028)

Table 54. GlaxoSmithKline Details, Company Type, Infectious Disease Drugs Area Served and Its Competitors

Table 55. GlaxoSmithKline Infectious Disease Drugs Product Offered

Table 56. GlaxoSmithKline Infectious Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. GlaxoSmithKline Main Business

Table 58. GlaxoSmithKline Latest Developments

Table 59. Gilead Sciences Details, Company Type, Infectious Disease Drugs Area Served and Its Competitors

Table 60. Gilead Sciences Infectious Disease Drugs Product Offered

Table 61. Gilead Sciences Main Business

Table 62. Gilead Sciences Infectious Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. Gilead Sciences Latest Developments

Table 64. Merck & Co. Details, Company Type, Infectious Disease Drugs Area Served and Its Competitors

Table 65. Merck & Co. Infectious Disease Drugs Product Offered

Table 66. Merck & Co. Main Business

Table 67. Merck & Co. Infectious Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Merck & Co. Latest Developments

Table 69. Pfizer Details, Company Type, Infectious Disease Drugs Area Served and Its Competitors

Table 70. Pfizer Infectious Disease Drugs Product Offered

Table 71. Pfizer Main Business

Table 72. Pfizer Infectious Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Pfizer Latest Developments

Table 74. Sanofi Details, Company Type, Infectious Disease Drugs Area Served and Its Competitors

Table 75. Sanofi Infectious Disease Drugs Product Offered

Table 76. Sanofi Main Business

Table 77. Sanofi Infectious Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Sanofi Latest Developments

Table 79. AbbVie Details, Company Type, Infectious Disease Drugs Area Served and Its Competitors

Table 80. AbbVie Infectious Disease Drugs Product Offered

Table 81. AbbVie Main Business

Table 82. AbbVie Infectious Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. AbbVie Latest Developments

Table 84. Shire Details, Company Type, Infectious Disease Drugs Area Served and Its Competitors

Table 85. Shire Infectious Disease Drugs Product Offered

Table 86. Shire Main Business

Table 87. Shire Infectious Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Shire Latest Developments

Table 89. Grifols Details, Company Type, Infectious Disease Drugs Area Served and Its Competitors

Table 90. Grifols Infectious Disease Drugs Product Offered

Table 91. Grifols Main Business

Table 92. Grifols Infectious Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Grifols Latest Developments

Table 94. Johnson & Johnson Details, Company Type, Infectious Disease Drugs Area Served and Its Competitors

Table 95. Johnson & Johnson Infectious Disease Drugs Product Offered

Table 96. Johnson & Johnson Main Business

Table 97. Johnson & Johnson Infectious Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. Johnson & Johnson Latest Developments

Table 99. Protein Sciences Details, Company Type, Infectious Disease Drugs Area Served and Its Competitors

Table 100. Protein Sciences Infectious Disease Drugs Product Offered

Table 101. Protein Sciences Main Business

Table 102. Protein Sciences Infectious Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 103. Protein Sciences Latest Developments

Table 104. AstraZeneca Details, Company Type, Infectious Disease Drugs Area Served and Its Competitors

Table 105. AstraZeneca Infectious Disease Drugs Product Offered

Table 106. AstraZeneca Infectious Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 107. AstraZeneca Main Business

Table 108. AstraZeneca Latest Developments

List of Figures

Figure 1. Infectious Disease Drugs Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Infectious Disease Drugs Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Infectious Disease Drugs Market Size Market Share by Type in 2021

Figure 7. Infectious Disease Drugs in HIV

Figure 8. Global Infectious Disease Drugs Market: HIV (2017-2022) & ($ Millions)

Figure 9. Infectious Disease Drugs in Malaria

Figure 10. Global Infectious Disease Drugs Market: Malaria (2017-2022) & ($ Millions)

Figure 11. Infectious Disease Drugs in Hepatitis

Figure 12. Global Infectious Disease Drugs Market: Hepatitis (2017-2022) & ($ Millions)

Figure 13. Infectious Disease Drugs in Influenza

Figure 14. Global Infectious Disease Drugs Market: Influenza (2017-2022) & ($ Millions)

Figure 15. Infectious Disease Drugs in HPV

Figure 16. Global Infectious Disease Drugs Market: HPV (2017-2022) & ($ Millions)

Figure 17. Infectious Disease Drugs in Tuberculosis

Figure 18. Global Infectious Disease Drugs Market: Tuberculosis (2017-2022) & ($ Millions)

Figure 19. Infectious Disease Drugs in Others

Figure 20. Global Infectious Disease Drugs Market: Others (2017-2022) & ($ Millions)

Figure 21. Global Infectious Disease Drugs Market Size Market Share by Application in 2021

Figure 22. Global Infectious Disease Drugs Revenue Market Share by Player in 2021

Figure 23. Global Infectious Disease Drugs Market Size Market Share by Regions (2017-2022)

Figure 24. Americas Infectious Disease Drugs Market Size 2017-2022 ($ Millions)

Figure 25. APAC Infectious Disease Drugs Market Size 2017-2022 ($ Millions)

Figure 26. Europe Infectious Disease Drugs Market Size 2017-2022 ($ Millions)

Figure 27. Middle East & Africa Infectious Disease Drugs Market Size 2017-2022 ($ Millions)

Figure 28. Americas Infectious Disease Drugs Value Market Share by Country in 2021

Figure 29. Americas Infectious Disease Drugs Consumption Market Share by Type in 2021

Figure 30. Americas Infectious Disease Drugs Market Size Market Share by Application in 2021

Figure 31. United States Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 32. Canada Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 33. Mexico Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 34. Brazil Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 35. APAC Infectious Disease Drugs Market Size Market Share by Region in 2021

Figure 36. APAC Infectious Disease Drugs Market Size Market Share by Application in 2021

Figure 37. China Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 38. Japan Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 39. Korea Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 40. Southeast Asia Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 41. India Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 42. Australia Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 43. Europe Infectious Disease Drugs Market Size Market Share by Country in 2021

Figure 44. Europe Infectious Disease Drugs Market Size Market Share by Type in 2021

Figure 45. Europe Infectious Disease Drugs Market Size Market Share by Application in 2021

Figure 46. Germany Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 47. France Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 48. UK Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 49. Italy Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 50. Russia Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 51. Middle East & Africa Infectious Disease Drugs Market Size Market Share by Region in 2021

Figure 52. Middle East & Africa Infectious Disease Drugs Market Size Market Share by Type in 2021

Figure 53. Middle East & Africa Infectious Disease Drugs Market Size Market Share by Application in 2021

Figure 54. Egypt Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 55. South Africa Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 56. Israel Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 57. Turkey Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 58. GCC Country Infectious Disease Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 59. Americas Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 60. APAC Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 61. Europe Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 62. Middle East & Africa Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 63. United States Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 64. Canada Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 65. Mexico Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 66. Brazil Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 67. China Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 68. Japan Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 69. Korea Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 70. Southeast Asia Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 71. India Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 72. Australia Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 73. Germany Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 74. France Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 75. UK Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 76. Italy Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 77. Russia Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 78. Spain Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 79. Egypt Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 80. South Africa Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 81. Israel Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 82. Turkey Infectious Disease Drugs Market Size 2023-2028 ($ Millions)

Figure 83. GCC Countries Infectious Disease Drugs Market Size 2023-2028 ($ Millions)